Distinguished from lung squamous cell carcinoma, lung adenocarcinoma has its unique biological and clinical characteristics, such as frequent mutations of epidermal growth factor receptor and anaplastic lymphoma kinase. Here, EGFR is linked to lung adenocarcinoma.